What is the recommended treatment for toenail fungus (onychomycosis)?

Treatment of Toenail Onychomycosis

Oral terbinafine 250 mg daily for 12-16 weeks is the first-line treatment for toenail onychomycosis caused by dermatophytes, based on superior efficacy, lower relapse rates, and better long-term outcomes compared to all alternatives. 1

Diagnostic Confirmation Required Before Treatment

• Never initiate treatment without mycological confirmation through microscopy and/or culture, as clinical appearance alone is insufficient 1
• Dermatophytes (particularly Trichophyton rubrum) cause the vast majority of toenail onychomycosis 1
• Yeast and non-dermatophyte molds require careful interpretation—they are often secondary infections or saprophytes in previously damaged nails 1

First-Line Systemic Treatment: Terbinafine

Terbinafine demonstrates markedly superior outcomes compared to itraconazole:

• Complete cure rates at 72 weeks: 55% with terbinafine vs. 26% with itraconazole 1
• Long-term mycological cure at 5 years: 46% with terbinafine vs. 13% with itraconazole 1
• Relapse rates significantly lower: 23% with terbinafine vs. 53% with itraconazole 1

Dosing regimen:

• 250 mg daily for 12-16 weeks for toenails (6 weeks for fingernails) 1
• Re-evaluate 3-6 months after treatment initiation; provide additional treatment if disease persists 1

Monitoring requirements:

• Baseline liver function tests and complete blood count recommended for patients with history of heavy alcohol consumption, hepatitis, or hematological abnormalities 1
• Not recommended in patients with active or chronic liver disease 1

Important adverse effect warning:

• Warn patients about rare but potentially permanent taste disturbance 1
• Most common side effects are gastrointestinal (49%) and dermatological (23%), but serious adverse events occur in only 0.04% 1

Second-Line Systemic Treatment: Itraconazole

Use itraconazole when terbinafine is contraindicated or not tolerated 1

Dosing options:

• Continuous: 200 mg daily for 12 weeks 1
• Pulse therapy: 400 mg daily for 1 week per month for 3 pulses (toenails) 1

Monitoring requirements:

• Monitor hepatic function tests in patients with pre-existing abnormalities, those receiving continuous therapy >1 month, and with concomitant hepatotoxic drugs 1
• Contraindicated in heart failure 1
• Take with food and acidic pH for optimal absorption 1

Third-Line Systemic Treatment: Fluconazole

Consider fluconazole only when both terbinafine and itraconazole cannot be used 1

• Dosing: 450 mg weekly for at least 6 months for toenails 1
• Mycological cure rates lower than terbinafine/itraconazole: 47-62% for toenails 1
• Advantage: once-weekly dosing may improve compliance 1
• Not licensed for onychomycosis treatment 1

Topical Therapy

Topical monotherapy is appropriate only for mild to moderate disease (<50-60% nail involvement) without matrix involvement 2

Efinaconazole 10% shows highest topical cure rates:

• Apply daily for 48 weeks 2
• Superior to amorolfine, ciclopirox, and tavaborole for mild-moderate disease 3, 2
• Can be considered off-label for maintenance to prevent recurrence 3

Alternative topical agents:

• Amorolfine 5% lacquer: once or twice weekly for 6-12 months 1
• Ciclopirox 8% lacquer: daily for up to 48 weeks 1
• Tavaborole: daily application 2

Combination Therapy

Combination of systemic and topical treatment is recommended when response to topical monotherapy alone would be poor 1

• Improves outcomes in moderate to severe disease 1
• Particularly useful when >60% nail involvement or matrix involvement present 4

Treatment Failure Management

When treatment fails (20-30% of cases), consider:

• Poor compliance, poor absorption, immunosuppression, or zero nail growth as causes 1
• Subungual dermatophytoma (tightly packed fungal mass) prevents adequate drug penetration—requires partial nail removal 1
• Switch to alternative systemic agent or combine nail removal with systemic therapy during regrowth period 1

Special Considerations for Candidal Onychomycosis

Itraconazole is most effective for Candida nail plate invasion:

• Pulse therapy: 400 mg daily for 1 week per month for 3-4 pulses (toenails) 1
• Most yeast infections with paronychia can be treated topically with imidazole lotion alternating with antibacterial lotion 1

Common Pitfalls to Avoid

• Starting treatment without mycological confirmation leads to inappropriate therapy 1
• Prescribing topical therapy for severe disease (>60% involvement) results in treatment failure 4
• Inadequate treatment duration—toenails require 12-18 months to fully regrow 3
• Failing to counsel patients about realistic expectations and follow-up requirements 3
• Not considering drug interactions, particularly with itraconazole which has extensive cytochrome P450 interactions 1